Cut
Tesamorelin
10 mg
GHRH analog, studied in clinical models of visceral adiposity and metabolic function.
$95
Start OrderFor laboratory and research use only. Not for human or animal consumption.
Read the researchSpecifications
| Format | Lyophilized powder |
|---|---|
| Amount per vial | 10 mg |
| Presentation | Single-use sealed vial |
| Storage | Store lyophilized vial refrigerated or frozen; once reconstituted, keep refrigerated (2–8°C). |
| Purity | Third-party tested to 99%+. |
| Intended use | Laboratory and research use only. |
Areas of Research Interest
- Visceral fat management, Tesamorelin has been studied for its selective effects on visceral adipose tissue reduction, independent of subcutaneous fat changes
- Metabolic syndrome, Research has examined effects on insulin sensitivity, glucose metabolism, and lipid profiles in models of metabolic dysfunction
- Cognitive aging, Studies have explored effects on cognitive function, neuroimaging biomarkers, and potential neuroprotection in age-related cognitive decline
- Liver health, Research investigates effects on hepatic fat accumulation and metabolic dysfunction-associated fatty liver disease
- Body composition and aging, Preclinical and clinical studies examine effects on lean muscle mass, bone density, and age-related metabolic changes
